ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $108,113 | -27.4% | 291,411 | -2.0% | 0.00% | – |
| Q3 2022 | $149,000 | -29.7% | 297,480 | -17.9% | 0.00% | – |
| Q2 2022 | $212,000 | -2.3% | 362,553 | +19.1% | 0.00% | – |
| Q1 2022 | $217,000 | -58.4% | 304,450 | -22.9% | 0.00% | – |
| Q4 2021 | $522,000 | +52.6% | 394,894 | +165.4% | 0.00% | – |
| Q3 2021 | $342,000 | -8.8% | 148,798 | +74.2% | 0.00% | – |
| Q2 2021 | $375,000 | +184.1% | 85,431 | +368.7% | 0.00% | – |
| Q1 2021 | $132,000 | -94.7% | 18,226 | -96.8% | 0.00% | – |
| Q4 2020 | $2,478,000 | +30.7% | 573,414 | +24.3% | 0.00% | – |
| Q3 2020 | $1,896,000 | -48.7% | 461,325 | -25.1% | 0.00% | -100.0% |
| Q2 2020 | $3,696,000 | +7442.9% | 616,105 | +9299.0% | 0.00% | – |
| Q1 2020 | $49,000 | -39.5% | 6,555 | +11.8% | 0.00% | – |
| Q4 2019 | $81,000 | -26.4% | 5,865 | -36.6% | 0.00% | – |
| Q3 2019 | $110,000 | +5400.0% | 9,250 | +6066.7% | 0.00% | – |
| Q2 2019 | $2,000 | -93.9% | 150 | -91.7% | 0.00% | – |
| Q1 2019 | $33,000 | -75.7% | 1,808 | -79.0% | 0.00% | – |
| Q4 2018 | $136,000 | – | 8,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |